Page results
-
Everyone is invited to share their views on the future of maternity, neonatal and children’s surgical services in North Central London as a 14-week public consultation launches today.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This information aims to help answer some of the questions that you may have about having a robotic bilateral salpingo-oophorectomy (removal of tubes and ovaries).
-
This page is for cancer patients receiving immunotherapy treatment.
-
Information for patients from overseas visiting UCLH hospitals.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
The best way to find out information about your relative is to contact the unit directly on the numbers provided.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
File results
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment
-
FOI/2024/0425 - Freedom of Information (FOI) structure, banding and job titles
-
FOI/2024/0426 - Agency staff spend for nursing, HCAs, pharmacists, occupational therapists and physiotherapists
-
FOI/2024/0428 - Physiotherapy/ occupational recruitment for 2023
-
FOI/2024/0431 - Hospital patient monitoring system on wards
-
FOI/2024/0438 - IT electronic signature software service/ e-Signatures
-
FOI/2024/0439 - Digital dictation provider
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy